Fort Washington Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.9M Sell
3,783
-124
-3% -$59.5K 0.01% 268
2026
Q1
$1.92M Sell
3,907
-248
-6% -$135K 0.01% 271
2025
Q4
$2.41M Buy
4,155
+38
+0.9% +$21.5K 0.01% 257
2025
Q3
$2M Sell
4,117
-512
-11% -$238K 0.01% 255
2025
Q2
$1.88M Sell
4,629
-382
-8% -$160K 0.01% 259
2025
Q1
$2.49M Sell
5,011
-98
-2% -$53.1K 0.02% 243
2024
Q4
$2.66M Buy
5,109
+507
+11% +$279K 0.02% 238
2024
Q3
$2.85M Buy
4,602
+415
+10% +$246K 0.02% 237
2024
Q2
$2.32M Buy
4,187
+292
+7% +$167K 0.02% 241
2024
Q1
$2.26M Buy
3,895
+20
+0.5% +$11.2K 0.01% 251
2023
Q4
$2.06M Buy
3,875
+1,005
+35% +$486K 0.01% 249
2023
Q3
$1.45M Buy
2,870
+303
+12% +$161K 0.01% 251
2023
Q2
$1.34M Buy
2,567
+210
+9% +$113K 0.01% 259
2023
Q1
$1.36M Buy
2,357
+10
+0.4% +$5.64K 0.01% 255
2022
Q4
$1.29M Buy
2,347
+3
+0.1% +$1.59K 0.01% 259
2022
Q3
$1.19M Sell
2,344
-110
-4% -$61.6K 0.01% 269
2022
Q2
$1.33M Sell
2,454
-57
-2% -$31.4K 0.01% 259
2022
Q1
$1.48M Sell
2,511
-20
-0.8% -$11.5K 0.01% 279
2021
Q4
$1.69M Sell
2,531
-44
-2% -$27.5K 0.01% 277
2021
Q3
$1.47M Sell
2,575
-255
-9% -$140K 0.01% 284
2021
Q2
$1.43M Hold
2,830
0.01% 288
2021
Q1
$1.29M Hold
2,830
0.01% 289
2020
Q4
$1.32M Buy
2,830
+350
+14% +$164K 0.01% 292
2020
Q3
$1.09M Sell
2,480
-24
-1% -$9.91K 0.01% 302
2020
Q2
$907K Buy
2,504
+130
+5% +$43.6K 0.01% 316
2020
Q1
$673K Buy
2,374
+219
+10% +$69.1K 0.01% 307
2019
Q4
$700K Sell
2,155
-47
-2% -$14.3K 0.01% 348
2019
Q3
$641K Hold
2,202
0.01% 367
2019
Q2
$647K Buy
2,202
+10
+0.5% +$2.75K 0.01% 361
2019
Q1
$600K Sell
2,192
-5,185
-70% -$1.29M 0.01% 371
2018
Q4
$1.65M Buy
7,377
+870
+13% +$204K 0.02% 289
2018
Q3
$1.59M Sell
6,507
-50
-0.8% -$11.5K 0.02% 317
2018
Q2
$1.36M Buy
6,557
+60
+0.9% +$12.7K 0.01% 324
2018
Q1
$1.34M Buy
6,497
+302
+5% +$63.4K 0.01% 344
2017
Q4
$1.18M Hold
6,195
0.01% 381
2017
Q3
$1.17M Sell
6,195
-55
-0.9% -$9.96K 0.02% 292
2017
Q2
$1.09M Buy
6,250
+23
+0.4% +$3.86K 0.02% 300
2017
Q1
$956K Sell
6,227
-48
-0.8% -$7.34K 0.02% 317
2016
Q4
$885K Sell
6,275
-450
-7% -$66.3K 0.01% 324
2016
Q3
$1.07M Hold
6,725
0.02% 261
2016
Q2
$994K Buy
6,725
+50
+0.7% +$7.38K 0.02% 276
2016
Q1
$945K Buy
+6,675
New +$895K 0.02% 291
2015
Q4
Sell
-9,660
Closed -$1.18M 433
2015
Q3
$1.18M Sell
9,660
-300
-3% -$39.1K 0.02% 264
2015
Q2
$1.29M Buy
9,960
+100
+1% +$13K 0.02% 242
2015
Q1
$1.32M Hold
9,860
0.03% 242
2014
Q4
$1.24M Buy
9,860
+110
+1% +$13.4K 0.02% 245
2014
Q3
$1.19M Buy
9,750
+530
+6% +$64.4K 0.02% 252
2014
Q2
$1.09M Buy
9,220
+2,400
+35% +$282K 0.02% 281
2014
Q1
$820K Buy
6,820
+35
+0.5% +$4.16K 0.02% 282
2013
Q4
$756K Buy
6,785
+980
+17% +$97.4K 0.02% 360
2013
Q3
$535K Hold
5,805
0.01% 356
2013
Q2
$491K Buy
+5,805
New +$483K 0.01% 350

Other funds holding TMO

Fort Washington Investment Advisors's TMO Position: Q2 2026 in Review

Fort Washington Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 3.2% in Q2 2026, selling an estimated $59.5K and leaving 3,783 shares worth $1.9M. The position accounts for 0.01% of the portfolio, ranked #268.

Fort Washington Investment Advisors first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.85M in Q3 2024. 994 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Fort Washington Investment Advisors held 3,783 shares of Thermo Fisher Scientific worth $1.9M as of Q2 2026.
  • Fort Washington Investment Advisors sold 124 Thermo Fisher Scientific shares in Q2 2026, an estimated $59.5K.
  • Thermo Fisher Scientific made up 0.01% of Fort Washington Investment Advisors's portfolio in Q2 2026, its #268 holding.
  • Fort Washington Investment Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Fort Washington Investment Advisors's Thermo Fisher Scientific position peaked at $2.85M in Q3 2024.
  • 994 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Fort Washington Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.